BPA call for prolastin-C
Ended Awarded Last action
- Contract number
- VA26018J2104
- Awardee
-
Grifols Therapeutics LLC UEI UFQ3A7GKJ5C7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $255,070
Award facts
- Contract value 100% obligated
- $255,070.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$4,130 | |
| Original award | $259,200 |
About this award
This is a firm fixed-price BPA call issued by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit limited liability company and manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin-C, a drug, with a potential value of $255,070.08 and a period of performance ending on September 30, 2018. The contract is placed off the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and does not utilize any small business set-asides. Grifols Therapeutics LLC has provided similar pharmaceutical products such as Prolastin and immune globulin to the VA and Defense Logistics Agency through past contract awards.
Quick answers
Who was awarded contract VA26018J2104?
VA26018J2104 was awarded to Grifols Therapeutics LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2017.
How much is contract VA26018J2104 worth?
The government has obligated $255,070 on VA26018J2104.
Is contract VA26018J2104 an order under another contract?
Yes. VA26018J2104 is a BPA call under V797D30042-VA797P13A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26018J2104 competed?
The extent of competition for VA26018J2104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award